RVMD

Revolution Medicines SVP Cislini sells $158,599 in shares

Revolution Medicines officer Mancini sells $743k in stock

Revolution Medicines director Elizabeth Anderson sells $1.96m in stock

Goldman Sachs initiates Revolution stock with buy rating on oncology platform

Chief global commercialization officer Mancini sells $347,402 of RVMD stock

Here's How Much $1000 Invested In Revolution Medicines 5 Years Ago Would Be Worth Today

Revolution Medicines CFO Jack Anders sells $807,513 in stock

Revolution Medicines COO Margaret Horn sells $989,612 of common stock

Axsome Therapeutics vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?

Revolution Medicines chief development officer sells $67,940 in stock

Revolution Medicines’ senior advisor sells $1.1m in stock

Revolution Medicines CEO Mark Goldsmith sells $2.78m in stock

Revolution Medicines’ Jeff Cislini sells $670k in common stock

Revolution Medicines Just Hit a Major Milestone. Is the Stock a Buy?

Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?